Use of Sodium Glucose Cotransporter 2 Inhibitors in the Hands of Cardiologists With Great Power Comes Great Responsibility

被引：54

作者：

Cherney, David Z. I. ^{[1
,3
,4
]}

Udell, Jacob A. ^{[2
,4
,5
,6
]}

机构：

[1] Toronto Gen Hosp, Div Nephrol, Dept Med, Toronto, ON, Canada

[2] Toronto Gen Hosp, Peter Munk Cardiac Ctr, Toronto, ON, Canada

[3] Univ Toronto, Dept Physiol, Banting & Best Diabet Ctr, Toronto, ON, Canada

[4] Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence Cardi, Dept Med, Toronto, ON, Canada

[5] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada

[6] Womens Coll Hosp, Cardiovasc Div, Dept Med, Toronto, ON, Canada

来源：

CIRCULATION | 2016年 / 134卷 / 24期

基金：

加拿大健康研究院;

关键词：

cardiovascular diseases; diabetes mellitus; heart failure; kidney; prevention and control; sodium-glucose transporter 2;

D O I：

10.1161/CIRCULATIONAHA.116.024764

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

[No abstract available]

引用

页码：1915 / 1917

页数：3

共 5 条

[1]

Policies, Guidelines and Consensus Statements: Pharmacologic Management of Type 2 Diabetese-2015 Interim Update [J].

Harper, William ;

Clement, Maureen ;

Goldenberg, Ronald ;

Hanna, Amir ;

Main, Andrea ;

Retnakaran, Ravi ;

Sherifali, Diana ;

Woo, Vincent ;

Yale, Jean-Francois ;

Cheng, Alice Y. Y. .

CANADIAN JOURNAL OF DIABETES, 2015, 39 (04) :250-252

[2]

Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications [J].

Heerspink, Hiddo J. L. ;

Perkins, Bruce A. ;

Fitchett, David H. ;

Husain, Mansoor ;

Cherney, David Z. I. .

CIRCULATION, 2016, 134 (10) :752-772

[3]

Rates of hyperkalemia after publication of the randomized aldactone evaluation study [J].

Juurlink, DN ;

Mamdani, MM ;

Lee, DS ;

Kopp, A ;

Austin, PC ;

Laupacis, A ;

Redelmeier, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (06) :543-551

[4]

Increased urine output by ipragliflozin in a non-diabetic patient with a diuretic-resistant heart failure [J].

Sairaku, Akinori ;

Nakano, Yukiko ;

Kihara, Yasuki .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 180 :42-43

[5]

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes [J].

Zinman, Bernard ;

Wanner, Christoph ;

Lachin, John M. ;

Fitchett, David ;

Bluhmki, Erich ;

Hantel, Stefan ;

Mattheus, Michaela ;

Devins, Theresa ;

Johansen, Odd Erik ;

Woerle, Hans J. ;

Broedl, Uli C. ;

Inzucchi, Silvio E. ;

Aizenberg, D. ;

Ulla, M. ;

Waitman, J. ;

De Loredo, L. ;

Farias, J. ;

Fideleff, H. ;

Lagrutta, M. ;

Maldonado, N. ;

Colombo, H. ;

Ferre Pacora, F. ;

Wasserman, A. ;

Maffei, L. ;

Lehman, R. ;

Selvanayagam, J. ;

d'Emden, M. ;

Fasching, P. ;

Paulweber, B. ;

Toplak, H. ;

Luger, A. ;

Drexel, H. ;

Prager, R. ;

Schnack, C. ;

Schernthaner, G. ;

Fliesser-Goerzer, E. ;

Kaser, S. ;

Scheen, A. ;

Van Gaal, L. ;

Hollanders, G. ;

Kockaerts, Y. ;

Capiau, L. ;

Chachati, A. ;

Persu, A. ;

Hermans, M. ;

Vantroyen, D. ;

Vercammen, C. ;

Van de Borne, P. ;

Mathieu, C. ;

Benhalima, K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (22) :2117-2128

← 1 →